Advanced glycation end products increase lipids accumulation in macrophages through upregulation of receptor of advanced glycation end products: increasing uptake, esterification and decreasing efflux of cholesterol

RAGE Suppresses ABCG1-Mediated Macrophage Cholesterol Efflux in Diabetes

(2015) Gurdip Daffu et al.   DIABETES

Molecular Mechanisms of Cellular Cholesterol Efflux

(2014) Michael C. Phillips   JOURNAL OF BIOLOGICAL CHEMISTRY

Advanced glycation end products promote hepatosteatosis by interfering with SCAP-SREBP pathway in fructose-drinking mice

(2013) Raffaella Mastrocola et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Receptor for advanced glycation end products (RAGE) in vascular and inflammatory diseases

(2013) Nitin Mahajan et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

ABCA1 mutation carriers with low high-density lipoprotein cholesterol are characterized by a larger atherosclerotic burden

(2012) A. E. Bochem et al.   EUROPEAN HEART JOURNAL

Current concept of reverse cholesterol transport and novel strategy for atheroprotection

(2012) Koh Ono   Journal of Cardiology

Regulation of Lipid Droplet Cholesterol Efflux From Macrophage Foam Cells

(2011) Mireille Ouimet et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Genetic Variation in ABCG1 and Risk of Myocardial Infarction and Ischemic Heart Disease

(2011) Jesper Schou et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Hypocholesterolemia, foam cell accumulation, but no atherosclerosis in mice lacking ABC-transporter A1 and scavenger receptor BI

(2011) Ying Zhao et al.   ATHEROSCLEROSIS

Receptor Mediated Elevation in FABP4 Levels by Advanced Glycation End Products Induces Cholesterol and Triacylglycerol Accumulation in THP-1 Macrophages

(2011) Xiao Qun Wang et al.   LIPIDS

RAGE, vascular tone and vascular disease

(2009) David G.S. Farmer et al.   PHARMACOLOGY & THERAPEUTICS

Macrophage cholesteryl ester mobilization and atherosclerosis

(2009) Shobha Ghosh et al.   VASCULAR PHARMACOLOGY

Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes

(2008) A. Soro-Paavonen et al.   DIABETES